USP <825> compliance survey

Thank you. We will be in contact with you shortly.

Get the full picture from trusted compliance experts

Our highly trained team performs site-specific surveys through staff interviews and thorough review and documentation of current policies, procedures and practices as they relate to standards outlined in USP General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging.

We also observe practices onsite, including but not limited to:

  • -Security of drugs/RAM
  • -Personnel qualification
  • -Formulary management
  • -Maintaining sterility
  • -Immediate use of sterile radiopharmaceuticals
  • -Red blood cell labeling
  • -End product release testing
  • -Radiation safety
  • -Quality assurance
  • -Documentation
  • -Facility controls
  • -Complaint handling

Cardinal Health manages the USP <825> compliance of its more than 130 nuclear pharmacies — so you can trust us to help your facility, too.

This survey is for educational purposes only and not intended as legal, compliance or business advice. Cardinal Health disclaims any and all warranties express or implied regarding the information provided. Each participant remains solely responsible for all compliance and legal requirements applicable to such participant’s own activities, including without limitation USP <825> compliance.